The US Court of Appeals for the Federal Circuit has affirmed a 2012 ruling that AstraZeneca’s patent for blockbuster antipsychotic drug Seroquel XR is valid and has been infringed by companies selling competing generics.
If you have already subscribed please login.
If you have any technical issues please email tech support.
AstraZeneca, Seroquel XR, Mylan, Torrent, Osmotica, infringement
